According to Marksans Pharma latest financial reports the total debt is $7.83M, an increase of 58.54% to 2022. At the end of 2022 company had $4.94M total debt. This figure represents the debts and financial obligations that Marksans Pharma combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Year | Total debt | Change |
---|---|---|
2023 | $7.83M | 58.54% |
2022 | $4.94M | 344.28% |
2021 | $1.11M | 24.01% |
2020 | $896.53K | Infinity% |
2019 | $0 | - |